Table 1 shows the distribution of demographic (age at diagnosis) and clinical characteristics (stage at diagnosis, clinical subtypes, PAM50 subtypes) among GR-high and GR-low breast cancer based on GR expression in METABRIC and TCGA. This evidence concerns the gene NR3C1 and breast carcinoma.